{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:09:30Z","timestamp":1772327370498,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.acuroe.2026.501903","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:16:05Z","timestamp":1767629765000},"page":"501903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New biomarker for erectile dysfunction: Soluble tumor necrosis factor-like weak inducer of apoptosis"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Iplikci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Efiloglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Erman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501903_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2003.11.041","article-title":"Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study","volume":"43","author":"Fung","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.acuroe.2026.501903_bib0020","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","article-title":"TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis","volume":"272","author":"Chicheportiche","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.acuroe.2026.501903_bib0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2013.00489","article-title":"Is TWEAK a biomarker for autoimmune\/chronic inflammatory diseases?","volume":"4","author":"Bertin","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11255-013-0562-4","article-title":"Soluble TWEAK levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease","volume":"46","author":"Azak","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0035","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurjhf\/hfp139","article-title":"Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure","volume":"11","author":"Chorianopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acuroe.2026.501903_bib0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2017.03.043","article-title":"Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease","volume":"260","author":"Fern\u00e1ndez-Laso","year":"2017","journal-title":"Atherosclerosis"},{"issue":"4 Pt 2","key":"10.1016\/j.acuroe.2026.501903_bib0045","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1743-6109.2010.01778.x","article-title":"Definitions\/epidemiology\/risk factors for sexual dysfunction","volume":"7","author":"Lewis","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuroe.2026.501903_bib0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/tud.2017.24886","article-title":"Prevalence of erectile dysfunction in men over 40 years of age in Turkey: results from the Turkish Society of Andrology Male Sexual Health Study Group","volume":"43","author":"\u00c7ayan","year":"2017","journal-title":"Turk J Urol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the Erectile Function domain of the International Index of Erectile Function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2026.501903_bib0060","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1743-6109.2010.02179.x","article-title":"What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy?","volume":"8","author":"Briganti","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuroe.2026.501903_bib0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jsxm.2017.04.672","article-title":"Exploring the optimal erectile function domain score cutoff that defines sexual satisfaction after radical prostatectomy","volume":"14","author":"Terrier","year":"2017","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuroe.2026.501903_bib0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.eururo.2006.07.015","article-title":"Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient","volume":"50","author":"Montorsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5694\/mja12.11548","article-title":"Risk factors for erectile dysfunction in a cohort of 108 477 Australian men","volume":"199","author":"Weber","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.acuroe.2026.501903_bib0080","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.eururo.2007.08.004","article-title":"Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links","volume":"52","author":"Vlachopoulos","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0085","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/andr.13206","article-title":"Novel predictive risk factor for erectile dysfunction: serum high-sensitivity C-reactive protein","volume":"10","author":"Liu","year":"2022","journal-title":"Andrology"},{"key":"10.1016\/j.acuroe.2026.501903_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/and.14337","article-title":"A systematic review and meta-analysis of the relationship between erectile dysfunction and the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios","volume":"54","author":"Zhang","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.acuroe.2026.501903_bib0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41443-019-0167-2","article-title":"The relationship between erectile dysfunction and the Atherogenic Index of Plasma","volume":"32","author":"Ermis","year":"2020","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.acuroe.2026.501903_bib0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.acuroe.2026.501903_bib0105","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.112.280958","article-title":"HDL and cardiovascular risk: time to call the plumber?","volume":"111","author":"Hewing","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.acuroe.2026.501903_bib0110","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/biomedicines9091083","article-title":"Is a high HDL-cholesterol level always beneficial?","volume":"9","author":"Franczyk","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.acuroe.2026.501903_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13685538.2019.1588873","article-title":"Complete blood count parameters in peripheral arterial disease","volume":"22","author":"Velioglu","year":"2019","journal-title":"Aging Male"},{"key":"10.1016\/j.acuroe.2026.501903_bib0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jcmm.12221","article-title":"Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice","volume":"18","author":"Sastre","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.acuroe.2026.501903_bib0125","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.109.195040","article-title":"Fn14-Fc fusion protein regulates atherosclerosis in ApoE-\/- mice and inhibits macrophage lipid uptake in vitro","volume":"29","author":"Schapira","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acuroe.2026.501903_bib0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjms.2022.05.003","article-title":"Can plasma TWEAK levels predict coronary slow flow in patients with chronic kidney disease?","volume":"364","author":"Tatlisu","year":"2022","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.acuroe.2026.501903_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","article-title":"Serum soluble CD163 predicts risk of type 2 diabetes in the general population","volume":"57","author":"M\u00f8ller","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.acuroe.2026.501903_bib0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2010.02.016","article-title":"Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome","volume":"211","author":"Chorianopoulos","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acuroe.2026.501903_bib0145","first-page":"336","article-title":"The diagnostic value of sTWEAK in acute ischemic stroke","volume":"37","author":"Comertpay","year":"2020","journal-title":"Balkan Med J"},{"key":"10.1016\/j.acuroe.2026.501903_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2018.01.011","article-title":"Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease","volume":"270","author":"Bozic","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:38:53Z","timestamp":1772325533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2173578626000193"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501903","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New biomarker for erectile dysfunction: Soluble tumor necrosis factor-like weak inducer of apoptosis","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501903","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501903"}}